Cassaday & Co Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$363K Buy
4,264
+208
+5% +$18.5K 0.01% 266
2025
Q4
$321K Sell
4,056
-1
-0% -$78 0.01% 276
2025
Q3
$324K Buy
4,057
+97
+2% +$8.27K 0.01% 269
2025
Q2
$360K Hold
3,960
0.01% 242
2025
Q1
$371K Hold
3,960
0.01% 228
2024
Q4
$360K Hold
3,960
0.01% 230
2024
Q3
$411K Sell
3,960
-12
-0.3% -$1.22K 0.01% 204
2024
Q2
$385K Sell
3,972
-19
-0.5% -$1.75K 0.01% 201
2024
Q1
$359K Buy
3,991
+31
+0.8% +$2.63K 0.01% 203
2023
Q4
$316K Hold
3,960
0.01% 198
2023
Q3
$282K Buy
3,960
+829
+26% +$62K 0.01% 200
2023
Q2
$241K Sell
3,131
-823
-21% -$63.7K 0.01% 224
2023
Q1
$297K Hold
3,954
0.01% 204
2022
Q4
$312K Buy
+3,954
New +$296K 0.01% 195

Other funds holding CL

Cassaday & Co Wealth Management's CL Position: Q1 2026 in Review

Cassaday & Co Wealth Management increased its Colgate-Palmolive (CL) stake by 5.1% in Q1 2026, buying an estimated $18.5K and bringing the position to 4,264 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #266.

Cassaday & Co Wealth Management first reported a position in CL in Q4 2022 and has held it in 14 quarters since. The position peaked at $411K in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Cassaday & Co Wealth Management held 4,264 shares of Colgate-Palmolive worth $363K as of Q1 2026.
  • Cassaday & Co Wealth Management bought 208 Colgate-Palmolive shares in Q1 2026, an estimated $18.5K.
  • Colgate-Palmolive made up 0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #266 holding.
  • Cassaday & Co Wealth Management first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • Cassaday & Co Wealth Management's Colgate-Palmolive position peaked at $411K in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.